For the Inventor, By the Inventor

Enter assignee name

Pittsburgh, PA, United States of America

Nsabp Foundation, Inc.

USPTO Granted Patents = 18

% Expired Patents = 5.6

CIPO Patents = 2

EPO Patents = 13

Trademarks = 1

Forward Citations = 431

Loading Chart...

Loading Chart...

12 inventors (with patents filed for the assignee):

Soonmyung Paik (18 out of 20 patents)

Joffre B Baker (17 out of 44 patents)

Drew Watson (10 out of 13 patents)

4. Wayne Cowens (10 out of 16 patents)

5. James Hackett (10 out of 16 patents)

6. Steven Shak (7 out of 24 patents)

7. John L Bryant (7 out of 10 patents)

8. Kim Clark (7 out of 8 patents)

9. Kim Langone (2 out of 2 patents)

10. Katherine Lea Pogue-Geile (1 out of 3 patents)

11. Nan Song (1 out of 1 patent)

12. Kim Clark-Langane (1 out of 1 patent)

13. Steve Shak (10 patents)

14. Soonmyung Paik (0 patent)

15. Soonmyung Paik (0 patent)

18 patents: Sort by Forward Citations

1. 10166210 - Methods of subtyping CRC and their association with treatment of colon cancer patients with oxaliplatin (2019-01-01),

2. 8868352 - Predicting response to chemotherapy using gene expression markers (2014-10-21),

3. 8632980 - Gene expression markers for prediction of patient response to chemotherapy (2014-01-21),

4. 8367345 - Gene expression markers for colorectal cancer prognosis (2013-02-05),

5. 8273537 - Gene expression markers for colorectal cancer prognosis (2012-09-25),

6. 8198024 - Gene expression markers for colorectal cancer prognosis (2012-06-12),

7. 8153380 - Gene expression markers for colorectal cancer prognosis (2012-04-10),

8. 8153379 - Gene expression markers for colorectal cancer prognosis (2012-04-10),

9. 8067178 - Gene expression markers for prediction of patient response to chemotherapy (2011-11-29),

10. 8029995 - Gene expression markers for colorectal cancer prognosis (2011-10-04),

11. 8026060 - Gene expression markers for colorectal cancer prognosis (2011-09-27),

12. 7939261 - Expression profile algorithm and test for cancer prognosis (2011-05-10),

13. 7930104 - Predicting response to chemotherapy using gene expression markers (2011-04-19),

14. 7723033 - Prediction of likelihood of cancer recurrence (2010-05-25),

15. 7695913 - Gene expression markers for colorectal cancer prognosis (2010-04-13),

NSABP Foundation, Inc. is a non-profit organization dedicated to preventing, treating, and curing breast cancer through innovative clinical and translational research. We conduct multi-disciplinary clinical trials, collaboratively providing transformative discoveries in the field of oncology. Our mission is to improve patient outcomes and reduce the impact of breast cancer worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

18 Patents

#121 in Pittsburgh, PA

#657 in Pennsylvania

#17,913 in US

#34,099 in the World

Pittsburgh, PA, United States of America

Nsabp Foundation, Inc.

Forward Citations = 431

12 inventors:

Soonmyung Paik (18 out of 20 patents)

Joffre B Baker (17 out of 44 patents)

Drew Watson (10 out of 13 patents)

4. Wayne Cowens (10 out of 16 patents)

5. James Hackett (10 out of 16 patents)

Please report any incorrect information to [email protected]

Loading…